CONTINUE TO SITE

OR WAIT null SECS

Novel Oligonucleotide Sample Clean-up and Method Optimizations It's Not “Just Analytical but With Bigger Columns”— Purification Insourcing and Technology Strategies How to Do More with Less: All Biopharmaceutical Batch Processes Can Benefit from Multi-Column Chromatography On Replication in Biopharmaceutical Analysis Tools for Investigating the Expanding Per- and Polyfluoroalkyl Substances Universe

Novel Oligonucleotide Sample Clean-up and Method OptimizationsIt's Not “Just Analytical but With Bigger Columns”— Purification Insourcing and Technology StrategiesHow to Do More with Less: All Biopharmaceutical Batch Processes Can Benefit from Multi-Column ChromatographyOn Replication in Biopharmaceutical AnalysisTools for Investigating the Expanding Per- and Polyfluoroalkyl Substances Universe

Topics

View More Liquid Chromatography (LC/HPLC)Gas Chromatography (GC)Sample Preparation Mass Spectrometry Pharmaceutical Analysis Environmental Analysis Food and Beverage Analysis

Liquid Chromatography (LC/HPLC)Gas Chromatography (GC)Sample PreparationMass SpectrometryPharmaceutical AnalysisEnvironmental AnalysisFood and Beverage Analysis

Publications

All Publications LCGC North America LCGC Europe LCGC Asia Pacific LCGC Supplements The Column E-Books The Application Notebook

All PublicationsLCGC North AmericaLCGC EuropeLCGC Asia PacificLCGC SupplementsThe ColumnE-BooksThe Application Notebook

All NewsInterviews

All App Notes Biological, Medical, and Clinical Biopharmaceuticals Cannabis Chiral Environmental Food and Beverage GC GC-MS General Industrial LC LC-MS Medical/Biological Misc Techniques Pharmaceuticals Polymers Sample Prep Size-Exclusion Chromatography (SEC)Supercritical Fluid Chromatography (SFC)

All App NotesBiological, Medical, and ClinicalBiopharmaceuticalsCannabisChiralEnvironmentalFood and BeverageGCGC-MSGeneralIndustrialLCLC-MSMedical/BiologicalMisc TechniquesPharmaceuticalsPolymersSample PrepSize-Exclusion Chromatography (SEC)Supercritical Fluid Chromatography (SFC)

E-Books Webcasts

Resources

Products ChromTube Events Analytically Speaking Podcast Podcasts Podcast Series Sponsored Videos Q&As Sponsored Content Content Engagement Hubs Tips & Tricks Industry Insights

ProductsChromTubeEventsAnalytically Speaking PodcastPodcastsPodcast SeriesSponsored VideosQ&AsSponsored ContentContent Engagement HubsTips & TricksIndustry Insights

Enewsletters Magazine North America Magazine Europe Magazine Asia Pacific The Column

EnewslettersMagazine North AmericaMagazine EuropeMagazine Asia PacificThe Column

Initial Development of SARS-CoV-2 Antigen Assay Using BAMS Technology and MALDI-TOF

October 15, 2020

Bruker Corporation

This work is focused on the development of a novel SARS-CoV-2 spike glycoprotein assay based on BAMS™ assay platform with detection by MALDI-TOF MS.